Cardiac Calcification
Cardiac Calcification - Related Videos
08:43
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
0 Views •
Cited by 26 •
2016
Vascular calcification is an important predictor of and contributor to human cardiovascular disease. This protocol describes methods for inducing calcification of cultured primary vascular smooth muscle cells and for quantifying calcification and macrophage burden in animal aortas using near-infrared fluorescence imaging.
08:55
Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
0 Views •
Cited by 17 •
2017
This protocol describes the isolation, culture, and calcification of rat-derived valve interstitial cells, a highly physiological in vitro model of calcific aortic valve disease (CAVD). Exploitation of this rat model facilitates CAVD research in exploring the cell and molecular mechanisms that underlie this complex pathological process.
15:39
Characterization of Calcification Events Using Live Optical and Electron Microscopy Techniques in a Marine Tubeworm
0 Views •
Cited by 3 •
2017
We demonstrate the use of various microscopy methods that are useful in observing the calcification of a tubeworm, Hydroides elegans, as well as locating and characterizing the first calcified material. Live microscopy and electron microscopy are used together to provide functional and material information that are important in studying biomineralization.
02:52
Calcification Assay to Measure Calcium Concentration in Aortic Valve Interstitial Cells
0 Views •
2025
This video demonstrates an assay technique for assessing the calcification of the aortic valve interstitial cells in vitro. The assay helps to quantify the calcium concentration using the arsenazo III reagent, a calcium-sensitive dye that reacts with calcium ions to form a purple-colored calcium-arsenazo complex.
03:10
Von Kossa Staining of Aortic Vascular Smooth Muscle Cells: An In Vitro Technique for Assessment of Arterial Medial Layer Calcification
0 Views •
2025
This video demonstrates a staining technique for assessing arterial medial calcification of the vascular smooth muscle cells in vitro. The von Kossa method employs a photochemical reaction to deposit metallic silver at the sites of calcification and impart a black coloration.
FAQs
Damaged or inflamed heart tissue can create conditions that favor calcium phosphate accumulation. This local environment changes how resident cells behave and may activate signaling pathways associated with bone formation. As a result, mineral deposition can progress within vulnerable cardiovascular structures, linking tissue injury and inflammatory activity to changes that may impair normal cardiac function.
An osteogenic phenotype means that resident cells acquire features associated with bone-forming activity. In cardiac calcification, signaling pathways linked to this phenotype can encourage mineral accumulation in tissues that normally should remain flexible or unobstructed. This mechanism helps explain why calcification can become an active biological process rather than simply a passive buildup of calcium.
The consequences depend partly on whether mineral deposition affects valves, coronary arteries, or the myocardium. Valve involvement can contribute to stiffening, arterial involvement can promote narrowing, and myocardial involvement can be associated with conduction abnormalities. Comparing these sites helps biologists relate the distribution of mineralized tissue to different forms of cardiovascular dysfunction.
Aging, kidney disease, and metabolic disorders are identified as factors that may increase susceptibility. These conditions do not by themselves determine the outcome, but they can create a biological context in which damaged or inflamed tissue is more likely to accumulate calcium phosphate. Considering these factors supports more informed study of risk and disease progression.
Research approaches include studying the cellular signaling associated with osteogenic change, examining factors linked to mineral deposition, and developing imaging methods for evaluating affected tissues. Investigators also assess risk patterns and explore treatments intended to slow progression. Together, these approaches connect molecular mechanisms with structural changes and potential effects on heart function.
This research can clarify how mineral deposition contributes to valve stiffening, arterial narrowing, and conduction abnormalities. It also supports risk assessment by relating susceptibility factors to cardiovascular changes. In applied settings, imaging and treatment studies may help evaluate disease burden and identify strategies designed to slow deposition while preserving heart function.